The changing landscape of chronic thromboembolic pulmonary hypertension management

Michael Madani, Takeshi Ogo, Gérald Simonneau

Source: Eur Respir Rev, 26 (146) 170105; 10.1183/16000617.0105-2017

Journal Issue: October

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Michael Madani, Takeshi Ogo, Gérald Simonneau. The changing landscape of chronic thromboembolic pulmonary hypertension management. Eur Respir Rev, 26 (146) 170105; 10.1183/16000617.0105-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

A roadmap for management of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 54 (4) 1901295; 10.1183/13993003.01295-2019 Year: 2019
Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape Source: Eur Respir Rev 2015; 24: 173-177 Year: 2015
Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options Source: Eur Respir Rev 2009; 18: 24-28 Year: 2009
Peculiarities of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 236s Year: 2002
Chronic thromboembolic pulmonary hypertension and associated medical conditions Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008
ERS statement on chronic thromboembolic pulmonary hypertension Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension Year: 2021
Diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2017; 26: 160108 Year: 2017
Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012
The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 52 (3) 1800589; 10.1183/13993003.00589-2018 Year: 2018
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018 Year: 2019
Management of chronic thromboembolic pulmonary hypertension (CTEPH): A physician-based perception study Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment Year: 2012
Real-life data on the medical therapy of pulmonary arterial and chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – PAH and CTEPH Year: 2017
Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017 Year: 2017
Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019
Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2012; 21: 27-31 Year: 2012
Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2009; 19: 64-67 Year: 2010